Antitrust investigation into Mylan begins over EpiPen
January 31, 2017Research and Development, Sales and Marketing Mylan, pricing
The Federal Trade Commission has submitted a request to Mylan for information as part of a preliminary investigation into whether …
First-line malaria treatment fails for the first time in UK
January 31, 2017Manufacturing and Production, Research and Development UK, malaria
The key combination malaria therapy artemether-lumefantrine has failed to treat UK patients for the first time, suggesting that the parasite …
Price-fixing class action lawsuit levelled at three major insulin producers
January 31, 2017Manufacturing and Production, Sales and Marketing Eli Lilly, Novo Nordisk, Sanofi, diabetes, insulin, price-fixing
A group of patients has filed a class action lawsuit in a federal court in Massachusetts, accusing three companies of …
Trump’s “one in, two out” regulatory order threatens FDA, Obama Cures Act
January 31, 2017Manufacturing and Production, Sales and Marketing FDA, Trump
An executive order signed by President Donald Trump on Monday has caused concern in the US pharma industry and beyond …
Teva hit by patent blow upon top-selling MS drug
January 31, 2017Manufacturing and Production Mylan, Teva, generic, multiple sclerosis
Teva endured a rough ride in 2016, seeing its market value sink progressively over the course of the year. It …
1,100% generic cancer drug price increases fly below UK radar
January 30, 2017Manufacturing and Production, Sales and Marketing Drug pricing, European Cancer congress
If you were asked what the big topic of discussion in the pharmaceutical industry was last year, there would really …
Sanofi announces new VP of External Affairs
January 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi
Kathleen Tregoning has been announced as Sanofi’s vice president of External Affairs and as a new member of the Executive …
Major pharma firms join Liverpool Uni in £14m pharmacovigilance project
January 30, 2017Research and Development, Sales and Marketing AZ, AbbVie, Eli Lilly, GSK, University of Liverpool, pharmacovigilance
The UK’s University of Liverpool is to launch a £14 million pharmacovigilance project focused on using new modelling approaches to …
Astellas and Ironwood release positive Phase 3 results for constipation drug
January 30, 2017Research and Development, Sales and Marketing Astellas, Ironwood, constipation
Astellas Pharma, a Tokyo-based pharmaceutical, and Ironwood Pharmaceuticals, based in Cambridge, Massachusetts, have announced positive results from a Phase 3 …
MSD puts best foot forward in drug pricing debate
January 30, 2017Medical Communications, Sales and Marketing Drug pricing, MSD, Merck
MSD, known as Merck in North America, has taken a pre-emptive step in the drug pricing debate by releasing its …
Amgen drug pair become first Humira biosimilars to win EU approval
January 30, 2017Sales and Marketing AbbVie, Amgen, Amgevita, Humira, Solymbic, rheumatoid arthritis
Good news for Amgen as its two biosimilar versions of AbbVie’s blockbuster rheumatoid arthritis (RA) drug Humira (adalimumab) have been …
Novo Nordisk launches £115 million investment in UK despite Brexit
January 30, 2017Research and Development, Sales and Marketing Novo Nordisk, University of Oxford, brexit
Novo Nordisk has given the UK a boost by confirming that it plans to go ahead with a £115 million …
Juno Therapeutics bring in new executive vice president
January 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, juno therapeutics
Juno Therapeutics has hired Corsee D. Sanders as its executive vice president and head of development operations. She will step …
Celgene’s Revlimid scores first-of-its-kind myeloma indication in EU
January 27, 2017Sales and Marketing Celgene, Revlimid, multiple myeloma
Celgene’s Revlimid (lenalidomide) has become the first licensed monotherapy treatment for newly diagnosed multiple myeloma in patients who have undergone …
Google’s life sciences business gains $800 million funding in pivot to Asia
January 27, 2017Medical Communications, Sales and Marketing China, Temasek, Verily, google
Verily, a life sciences company owned by Alphabet, Google’s umbrella company, has announced that it has received $800 million in …
Five most talked about mergers and acquisitions of 2016
January 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Bayer, Boehringer, Johnson & Johnson, Sanofi, Teva, acquisition, mergers, monsanto, pharma
2017 has kicked off with a bang – as Johnson & Johnson confirmed a $30 billion deal to takeover of …
Top Ten most popular articles on Pharmafile.com this week
January 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest news, biggest stories, top 10, top 10 stories, top stories, top ten
We’re nearing the end of the first month of the year and acqusitions have begun to introduce themselves with bang, …
Innovative routes to market: Rethinking the life sciences distribution model
January 27, 2017Manufacturing and Production, Medical Communications, Sales and Marketing Deloitte, distribution
Originally published in the latest issue of Pharmafile, Deloitte’s life sciences director Lee Feander discusses the often-undervalued importance of distribution …
Celgene to acquire Delinia in a potential $775 million deal
January 27, 2017Medical Communications Celgene, Delinia
Celgene has shelled out $300 million upfront, with a potential further $475 million in milestone payments, for Delinia, an autoimmune …
Skin cancer-detecting AI “on par with board-certified dermatologists”
January 27, 2017Medical Communications, Research and Development AI, Cancer, skin cancer
New research has found that artificial intelligence repurposed by researchers at Stanford University to identify skin cancer in images has …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
